Literature DB >> 12105275

Ligand-independent growth hormone receptor dimerization occurs in the endoplasmic reticulum and is required for ubiquitin system-dependent endocytosis.

Jürgen Gent1, Peter van Kerkhof, Marcel Roza, Guojun Bu, Ger J Strous.   

Abstract

The regulatory effect of growth hormone (GH) on its target cells is mediated via the GH receptor (GHR). GH binding to the GHR results in the formation of a GH-(GHR)(2) complex and the initiation of signal transduction cascades via the activation of the tyrosine kinase JAK2. Subsequent endocytosis and transport to the lysosome of the ligand-receptor complex is regulated via the ubiquitin system and requires the presence of an intact ubiquitin-dependent endocytosis (UbE) motif in the cytosolic tail of the GHR. Recently, the model of ligand-induced receptor dimerization has been challenged. In this study, ligand-independent GHR dimerization is demonstrated in the endoplasmic reticulum and at the cell surface by coimmunoprecipitation of an epitope-tagged truncated GHR with wild-type GHR. In addition, evidence is provided that the extracellular domain of the GHR is not required to maintain this interaction. Internalization of a chimeric receptor, which fails to dimerize, is independent of an intact UbE-motif. Therefore, we postulate that dimerization of GHR molecules is required for ubiquitin system-dependent endocytosis.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12105275      PMCID: PMC125043          DOI: 10.1073/pnas.152294299

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  41 in total

Review 1.  Intracellular aspects of the process of protein synthesis.

Authors:  G Palade
Journal:  Science       Date:  1975-08-01       Impact factor: 47.728

2.  The ubiquitin-proteasome pathway regulates the availability of the GH receptor.

Authors:  Peter van Kerkhof; Mirjam Smeets; Ger J Strous
Journal:  Endocrinology       Date:  2002-04       Impact factor: 4.736

3.  Rational design of potent antagonists to the human growth hormone receptor.

Authors:  G Fuh; B C Cunningham; R Fukunaga; S Nagata; D V Goeddel; J A Wells
Journal:  Science       Date:  1992-06-19       Impact factor: 47.728

4.  Structural design and molecular evolution of a cytokine receptor superfamily.

Authors:  J F Bazan
Journal:  Proc Natl Acad Sci U S A       Date:  1990-09       Impact factor: 11.205

5.  A Chinese hamster cell cycle mutant arrested at G2 phase has a temperature-sensitive ubiquitin-activating enzyme, E1.

Authors:  R G Kulka; B Raboy; R Schuster; H A Parag; G Diamond; A Ciechanover; M Marcus
Journal:  J Biol Chem       Date:  1988-10-25       Impact factor: 5.157

6.  Glycophorin A dimerization is driven by specific interactions between transmembrane alpha-helices.

Authors:  M A Lemmon; J M Flanagan; J F Hunt; B D Adair; B J Bormann; C E Dempsey; D M Engelman
Journal:  J Biol Chem       Date:  1992-04-15       Impact factor: 5.157

7.  Human growth hormone and extracellular domain of its receptor: crystal structure of the complex.

Authors:  A M de Vos; M Ultsch; A A Kossiakoff
Journal:  Science       Date:  1992-01-17       Impact factor: 47.728

8.  A specific growth hormone-binding protein in human plasma: initial characterization.

Authors:  G Baumann; M W Stolar; K Amburn; C P Barsano; B C DeVries
Journal:  J Clin Endocrinol Metab       Date:  1986-01       Impact factor: 5.958

9.  Dimerization of the extracellular domain of the human growth hormone receptor by a single hormone molecule.

Authors:  B C Cunningham; M Ultsch; A M De Vos; M G Mulkerrin; K R Clauser; J A Wells
Journal:  Science       Date:  1991-11-08       Impact factor: 47.728

10.  Surface location and high affinity for calcium of a 500-kd liver membrane protein closely related to the LDL-receptor suggest a physiological role as lipoprotein receptor.

Authors:  J Herz; U Hamann; S Rogne; O Myklebost; H Gausepohl; K K Stanley
Journal:  EMBO J       Date:  1988-12-20       Impact factor: 11.598

View more
  55 in total

1.  Growth hormone and in vitro maturation of rhesus macaque oocytes and subsequent embryo development.

Authors:  Jenna K Nyholt de Prada; Catherine A VandeVoort
Journal:  J Assist Reprod Genet       Date:  2008-04       Impact factor: 3.412

Review 2.  Nonclassical GH Insensitivity: Characterization of Mild Abnormalities of GH Action.

Authors:  Helen L Storr; Sumana Chatterjee; Louise A Metherell; Corinne Foley; Ron G Rosenfeld; Philippe F Backeljauw; Andrew Dauber; Martin O Savage; Vivian Hwa
Journal:  Endocr Rev       Date:  2019-04-01       Impact factor: 19.871

3.  Mechanism of homodimeric cytokine receptor activation and dysregulation by oncogenic mutations.

Authors:  Stephan Wilmes; Maximillian Hafer; Joni Vuorio; Julie A Tucker; Hauke Winkelmann; Sara Löchte; Tess A Stanly; Katiuska D Pulgar Prieto; Chetan Poojari; Vivek Sharma; Christian P Richter; Rainer Kurre; Stevan R Hubbard; K Christopher Garcia; Ignacio Moraga; Ilpo Vattulainen; Ian S Hitchcock; Jacob Piehler
Journal:  Science       Date:  2020-02-07       Impact factor: 47.728

4.  Multimeric growth hormone receptor complexes serve as signaling platforms.

Authors:  Magdalena Sedek; Lieke M van der Velden; Ger J Strous
Journal:  J Biol Chem       Date:  2013-11-26       Impact factor: 5.157

5.  The growth hormone receptor interacts with its sheddase, the tumour necrosis factor-alpha-converting enzyme (TACE).

Authors:  Julia A Schantl; Marcel Roza; Peter Van Kerkhof; Ger J Strous
Journal:  Biochem J       Date:  2004-01-15       Impact factor: 3.857

6.  Small glutamine-rich tetratricopeptide repeat-containing protein (SGT) interacts with the ubiquitin-dependent endocytosis (UbE) motif of the growth hormone receptor.

Authors:  Julia A Schantl; Marcel Roza; Ad P De Jong; Ger J Strous
Journal:  Biochem J       Date:  2003-08-01       Impact factor: 3.857

7.  LEPROT and LEPROTL1 cooperatively decrease hepatic growth hormone action in mice.

Authors:  Thierry Touvier; Françoise Conte-Auriol; Olivier Briand; Céline Cudejko; Réjane Paumelle; Sandrine Caron; Eric Baugé; Yves Rouillé; Jean-Pierre Salles; Bart Staels; Bernard Bailleul
Journal:  J Clin Invest       Date:  2009-11-09       Impact factor: 14.808

8.  Excessive growth hormone expression in male GH transgenic mice adversely alters bone architecture and mechanical strength.

Authors:  S V Lim; M Marenzana; M Hopkinson; E O List; J J Kopchick; M Pereira; B Javaheri; J P Roux; P Chavassieux; M Korbonits; C Chenu
Journal:  Endocrinology       Date:  2015-02-03       Impact factor: 4.736

9.  Intramolecular disulfide bonds of the prolactin receptor short form are required for its inhibitory action on the function of the long form of the receptor.

Authors:  Y-L Xie; S A Hassan; A M Qazi; C H Tsai-Morris; M L Dufau
Journal:  Mol Cell Biol       Date:  2009-03-09       Impact factor: 4.272

Review 10.  Modulation of growth hormone receptor abundance and function: roles for the ubiquitin-proteasome system.

Authors:  Stuart J Frank; Serge Y Fuchs
Journal:  Biochim Biophys Acta       Date:  2008-06-09
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.